Clinical Trials Browser

Phase 2 × Gefitinib × Other hematologic neoplasm × Clear all

NCT00130702 2014-05-01

Study of Iressa in Patients With Relapsed or Refractory Acute Myelogenous Leukemia

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute